Connect with others who understand.

Sign up Log in
Quick Links
Q&A Treatments A-Z Help Center Guidelines Crisis Accessibility
Resources
Diagnosis & Information Managing Your Condition Treating Lymphoma All Resources
About MyLymphomaTeam
What is This Site Terms of Use Privacy policy
Powered By
Real members of MyLymphomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

Is Anyone Participating In The UC Davis Clinical Trial For Follicular Lymphoma (obinutuzumabt/ibrutinab/venetoclax)?

A MyLymphomaTeam Member asked a question 💭
Clovis, CA
April 14
•
Be the first to like/hug
A MyLymphomaTeam Member

Good luck

April 16
A MyLymphomaTeam Member

Thanks Frank, I am going to go this route if I’m allowed into the trial. I’ll know this Friday. Hopeful.

April 15
A MyLymphomaTeam Member

Obinutuzumabt is a monoclonal antibody to aCD20 marker president on lymphoma cell s.Similar to rituxin but said to be more effective and less toxic

Venetolax attacks bcl2 antigen on the surface of lymphoma cells and allows the to self destruct
Very cutting edge effective treatment good oncologist

April 15

Related content

View All

Been On Ibrutinib, Venetoclax, Or Obinutuzumab? If So, Any Issues With Nausea Or Hair Loss?

A MyLymphomaTeam Member asked a question 💭
Clovis, CA
June 15

Has Anyone Ever Been Diagnosed With Two Different Types Of Lymphoma?

A MyLymphomaTeam Member asked a question 💭
May 15, 2021

I Have Follicular Lymphoma. I'm Trying To Find Out If Anybody Has Had Antibodies. I Can't Take Any More Of The Adromycin.

A MyLymphomaTeam Member asked a question 💭
Mandeville, LA
April 30, 2023
Understanding Immunotherapy for Lymphoma
Oral Treatments vs. Chemotherapy for Indolent Non-Hodgkin Lymphoma (NHL)
Relapsed and Refractory Follicular Lymphoma: Treatments, Symptoms, and Rates
Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data Policy and Privacy policies.Your privacy is our priority Lock Icon
Already a Member? Log in